VP Cell Therapy Solid Tumor Franchise Head

AstraZeneca•Gaithersburg, MD

About The Position

Leads the Solid Tumor Cell Therapy Franchise by defining the strategic direction and priorities of the portfolio and overseeing portfolio strategy execution by the Global Product Teams (GPTs). Line manages the GPLs within the solid tumor portfolio providing effective leadership and coaching to create a high performing, empowered GPT environment while guiding and endorsing critical GPT decisions, e.g., Target Product Profile (TPP), investment decisions and agreements with the business. Serves as single point of contact for all solid tumor cell therapy assets for internal and external stakeholders, for example the Therapeutic Area Clinical Development Leads, the Cell Therapy Discovery organization and Cell Therapy Technical Operations. Identifies opportunities for the portfolio and drives decisions by coalescing diverse internal and external stakeholders’ interests. Acts as an ambassador for AZ Cell Therapy and the solid tumor cell therapy portfolio with our internal partners and external collaborators, with representatives from the scientific community and health authorities, and in any interactions with health care practitioners and patients. Ensure appropriate Governance and Compliance and protect AZ’s Rights, Data and Intellectual Property.

Requirements

MD/PhD or both
Minimum of 10 years of experience in industry
Deep understanding of Oncology drug development
A deep and broad understanding of the global pharmaceutical industry and of the key value creating processes within the industry, in particular designing development strategies through all stages of development
Ideally US/Global commercial launch experience
Experience leading Oncology projects across discovery through to late phase development
Experience working in a dynamic global environment ideally demonstrated by having been successfully leading GPTs as GPL
Extensive leadership experience
Excellent communication skills

Responsibilities

Defining the strategic direction and priorities of the portfolio
Overseeing portfolio strategy execution by the Global Product Teams (GPTs)
Line managing the GPLs within the solid tumor portfolio
Providing effective leadership and coaching to create a high performing, empowered GPT environment
Guiding and endorsing critical GPT decisions, e.g., Target Product Profile (TPP), investment decisions and agreements with the business
Serving as single point of contact for all solid tumor cell therapy assets for internal and external stakeholders
Identifying opportunities for the portfolio and driving decisions by coalescing diverse internal and external stakeholders’ interests
Acting as an ambassador for AZ Cell Therapy and the solid tumor cell therapy portfolio with internal partners and external collaborators, scientific community, health authorities, health care practitioners and patients
Ensuring appropriate Governance and Compliance
Protecting AZ’s Rights, Data and Intellectual Property